Literature DB >> 28919333

Status of the effectiveness of contact lens disinfectants in Malaysia against keratitis-causing pathogens.

Farhat Abjani1, Naveed Ahmed Khan1, Suk Yul Jung2, Ruqaiyyah Siddiqui3.   

Abstract

The aim of this study was (i) to assess the antimicrobial effects of contact lens disinfecting solutions marketed in Malaysia against common bacterial eye pathogens and as well as eye parasite, Acanthamoeba castellanii, and (ii) to determine whether targeting cyst wall would improve the efficacy of contact lens disinfectants. Using ISO 14729 Stand-Alone Test for disinfecting solutions, bactericidal and amoebicidal assays of six different contact lens solutions including Oxysept®, AO SEPT PLUS, OPTI-FREE® pure moist®, Renu® fresh™, FreshKon® CLEAR and COMPLETE RevitaLens™ were performed using Manufacturers Minimum recommended disinfection time (MRDT). The efficacy of contact lens solutions was determined against keratitis-causing microbes, namely: Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, and Acanthamoeba castellanii. In addition, using chlorhexidine as an antiamoebic compound and cellulase enzyme to disrupt cyst wall structure, we determined whether combination of both agents can enhance efficacy of marketed contact lens disinfectants against A. castellanii trophozoites and cysts, in vitro. The results revealed that all contact lens disinfectants tested showed potent bactericidal effects exhibiting 100% kill against all bacterial species tested. In contrast, none of the contact lens disinfectants had potent effects against Acanthamoeba cysts viability. When tested against trophozoites, two disinfectants, Oxysept Multipurpose and AO-sept Multipurpose showed partial amoebicidal effects. Using chlorhexidine as an antiamoebic compound and cellulase enzyme to disrupt cyst wall structure, the findings revealed that combination of both agents in contact lens disinfectants abolished viability of A. castellanii cysts and trophozoites. Given the inefficacy of contact lens disinfectants tested in this study, these findings present a significant concern to public health. These findings revealed that targeting cyst wall by using cyst wall degrading molecules in contact lens disinfecting solutions will enhance their efficacy against this devastating eye infection.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acanthamoeba; Bacteria; Contact lens disinfectants; Eye pathogens; Keratitis

Mesh:

Substances:

Year:  2017        PMID: 28919333     DOI: 10.1016/j.exppara.2017.09.007

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  5 in total

1.  Susceptibility of Contact Lens-Related Pseudomonas aeruginosa Keratitis Isolates to Multipurpose Disinfecting Solutions, Disinfectants, and Antibiotics.

Authors:  Mahjabeen Khan; Fiona Stapleton; Mark Duncan Perry Willcox
Journal:  Transl Vis Sci Technol       Date:  2020-04-09       Impact factor: 3.283

2.  In vitro effects of multi-purpose contact lens disinfecting solutions towards survivability of Acanthamoeba genotype T4 in Malaysia.

Authors:  Rosnani Hanim Mohd Hussain; Wan Nur Afiqah; Mohamed Kamel Abdul Ghani; Naveed Ahmed Khan; Ruqaiyyah Siddiqui; Tengku Shahrul Anuar
Journal:  Saudi J Biol Sci       Date:  2021-01-26       Impact factor: 4.219

Review 3.  Common Ophthalmic Preservatives in Soft Contact Lens Care Products: Benefits, Complications, and a Comparison to Non-Preserved Solutions.

Authors:  Chelsea S Bradley; Lindsay A Sicks; Andrew D Pucker
Journal:  Clin Optom (Auckl)       Date:  2021-09-07

4.  Novel Plant-Based Metabolites as Disinfectants against Acanthamoeba castellanii.

Authors:  Ruqaiyyah Siddiqui; Noor Akbar; Bushra Khatoon; Muhammad Kawish; Muhammad Shaiq Ali; Muhammad Raza Shah; Naveed Ahmed Khan
Journal:  Antibiotics (Basel)       Date:  2022-02-14

5.  Antibiotic Resistance Characteristics of Pseudomonas aeruginosa Isolated from Keratitis in Australia and India.

Authors:  Mahjabeen Khan; Fiona Stapleton; Stephen Summers; Scott A Rice; Mark D P Willcox
Journal:  Antibiotics (Basel)       Date:  2020-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.